Vident Advisory’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.06M | Sell |
27,517
-857
| -3% | -$32.9K | 0.01% | 716 |
|
|
2025
Q1 | $1.1M | Buy |
28,374
+8,294
| +41% | +$321K | 0.02% | 691 |
|
|
2024
Q4 | $679K | Buy |
20,080
+813
| +4% | +$27.5K | 0.01% | 811 |
|
|
2024
Q3 | $788K | Buy |
19,267
+1,735
| +10% | +$70.9K | 0.02% | 722 |
|
|
2024
Q2 | $675K | Buy |
17,532
+5,698
| +48% | +$219K | 0.02% | 745 |
|
|
2024
Q1 | $507K | Buy |
11,834
+1,173
| +11% | +$50.3K | 0.01% | 820 |
|
|
2023
Q4 | $395K | Buy |
10,661
+971
| +10% | +$36K | 0.01% | 887 |
|
|
2023
Q3 | $351K | Buy |
+9,690
| New | +$351K | 0.01% | 828 |
|